Is GoPro Done After This Delay?
GoPro shares were crushed on Thursday after the firm announced that there would be a delay in shipments of its new Hero8 Black cameras.
All Work
Chris Lange
Why Canopy Growth Is Pulling Down Constellation Brands’ Earnings
Constellation Brands reported better than expected fiscal second-quarter earnings early Thursday but made a big change to its guidance.
Pepsi Pops Off in Q3
PepsiCo released better than expected third-quarter financial results before the markets opened on Thursday.
Bed Bath & Beyond Squeaks By in Q2
Bed Bath & Beyond reported its fiscal second quarter financial results after the markets closed on Wednesday. The retailer said that it had $0.34 in earnings per share (EPS) and $2.7 billion in revenue,…
What to Expect When Pepsi Reports Thursday Morning
PepsiCo is set to report its third-quarter financial results before the markets open on Thursday, and analysts are looking for growth on the bottom line.
Canopy Growth’s Next Step for Weed Domination
Canopy Growth shares dipped on Wednesday following the markets lower after the firm announced that it will purchase a majority stake in a leading producer of sports nutrition products.
What to Expect When Bed Bath & Beyond Reports After the Close
Bed Bath & Beyond is scheduled to release its fiscal second-quarter financial results after the markets close on Wednesday.
Will TSG and Flutter Get Lucky Creating the World’s Biggest Online Betting Site
The Stars Group shares exploded on Wednesday after the firm announced that it will be acquired by Flutter Entertainment in an all-share combination. This deal will form the world’s largest online betting company.
Johnson & Johnson May Have Just Dodged a Big Opioid Bullet
One analyst issued a fairly bullish report in response to Johnson & Johnson's announcement of a $10 million settlement with two Ohio counties ahead of an upcoming opioid trial.
FDA Accepts for Review the Newest Treatment for C Diff
Merck has just announced that the FDA has accepted a couple new drug applications for review, including for a treatment for Clostridium difficile infections in children.
Are Stitch Fix Earnings Big Enough to Fend Off the Bears?
Stitch Fix released its fiscal fourth quarter financial results after the markets closed on Tuesday. The after-hours session has seen ridiculous swings in the stock as the bulls and bears are fighting this one…
Would Stryker Be Better Off Buying Conformis?
Conformis shares shot up on Tuesday after the firm announced that it has entered into definitive agreements to sell and license to Stryker to develop, manufacture and supply PSI for use in connection with…
HBT Financial Gears Up for IPO
Bank holding company HBT Financial expects to price 8.3 million shares to result in an initial public offering valued up to more than $181 million.
What to Expect When Stitch Fix Reports After the Close
Stitch Fix is scheduled to release its fiscal fourth-quarter financial results after the markets close on Tuesday.
Are Biotechs the Next Target for Cyber Criminals?
Minerva Neurosciences shares dropped sharply on Tuesday after the firm announced that it was the victim of a cyberattack. Minerva also provided an update on its clinical trials.
Major Duchenne Muscular Dystrophy Trial Is Ready to Launch
Catabasis Pharma shares jumped early on Tuesday after the firm announced that it had completed the enrollment for its late-stage Duchenne muscular dystrophy (DMD) study. Specifically, the enrollment is for the Phase 3 PolarisDMD…
Chapter 11 for Forever 21
The retail chain that embraces an eternal youthful disposition, Forever 21, may not be around for too much longer after the company voluntarily filed for Chapter 11 bankruptcy over the weekend.
Why This Finally Could Be Bed Bath & Beyond’s Time to Shine
Bed Bath & Beyond is scheduled to release its most recent quarterly results later this week. One analyst is getting out ahead of the report and believes that it is this struggling retailer’s time…
Why This Successful Bladder Cancer Study May Not Be Enough
Immunomedics shares dropped sharply on Monday after the firm presented interim data from its midstage bladder cancer study at the European Society for Medical Oncology (ESMO) Annual Congress in Barcelona, Spain.
It’s Official, WeWork Is Out
WeWork has formally filed with the SEC its intention to no longer come public. This company has been plagued by bad press as analysts have slashed its valuation over the course of this year.